Fluidic Analytics Ltd, a pioneer in protein evaluation and the corporate behind in-solution diffusional sizing, will attend quite a lot of events this Autumn to showcase its revolutionary technology for studying protein interactions. At each event across Europe, the team will present data from its pre-release instrument – the Fluidity One-W – which allows researchers to evaluate on-target protein interactions in solution and even in crude biological backgrounds.

The Fluidity One-W opens up the probabilities for detailed protein evaluation in near-native states and natural environments, providing researchers with accurate and complete protein interaction data. Its ability to generate absolute size measurements through the proprietary approach to microfluidic diffusional sizing (MDS) ensures confidence in the info collected and allows users to regulate for off-target binding and false positive measurements. Detailed protein interaction information including binding kinetics, KD calculations and stoichiometries might be generated, allowing researchers to realize the very best insight right into a protein’s behavior within the cell. The Fluidity One-W can be remarkably easy-to-use, operating on a pipette, plug and play basis with minimal sample preparation to cut back time and costs and permit evaluation on the earliest possible stage.

At quite a lot of the European events, Fluidic Analytics will likely be presenting data and talking in regards to the recent possibilities for protein evaluation with MDS during short talks:

• Dutch BioPhysics (Veldhoven, Netherlands, Seventh-Eighth October)
• Tools for the structural biology of membrane proteins (Hamburg, Germany, Seventh-Ninth October)
• BSI-2019 (Toulouse, France, Seventh-Eleventh October)
  • Including a 15-minute presentation, Tuesday Eighth @ 09.15
• GPCR International Meeting (Montpellier, France, Ninth-Eleventh October)
  • Including a 5-minute presentation, Friday Eleventh @ 10.55
• PSDI 2019 (Cambridge, UK, Third-Fifth November)
• Drug Discovery 2019 (Liverpool, UK, Fifth-Sixth November)
• Bioscience 2019 (Stockholm, Sweden, Seventh November)
  • Including a 20-minute presentation – timing TBC

“We’re really looking forward to presenting recent data and showcasing our newest instrument, the Fluidity One-W, ahead of its release later within the yr. It’s a very exciting platform, that has an entire range of applications from neurobiology and structural biology to drug discovery. With its unique capabilities in-solution, the Fluidity One-W is the very best option for analyzing difficult-to-study proteins like amyloid fibrils and enormous complexes, and so having one within the laboratory can really expand the sorts of proteins and systems that might be investigated. With our recent approach to protein evaluation, researchers can make certain of accurate, quality data for occasionally previously inaccessible targets”

Dr Sean Devenish, Fluidic Analytics